Search
Jack Silberstein's startup, Deck Bio, received a "Golden Ticket" award from Servier - he and Servier's Irene Blat discuss how it is one of the many ways larger companies help biotech entrepreneurs
Servier's 'Golden Ticket' gave Deck Bio a place to work at LabCentral and access to Servier's experts for advice. Jack and Irene discuss the benefits of this kind of support to a smaller company, and other ways more established players nurture the biotech ecosystem in hubs like Kendall Square. Chapters Intros - 0:07 Deck Bio - 1:25 The value of collaboration - 2:22 What Servier looks for in collaborators - 3:07 Jack's clinical background perspective - 6:06 Support from the La
Dec 19, 2025
Servier's U.S. CEO discusses FDA approval of Voranigo, a targeted therapy for a common type of brain cancer
David Lee describes the glioma brain cancer population this IHD1/2 targeting therapy is for, Servier's experience commercializing cancer...
Aug 7, 2024
.png){kind=logo}
